KURA

Kura Oncology, Inc. · Healthcare · Market cap $634.9M

Insiders bought $762K net in the last 90 days ·6 sellers, 1 buyer· 14 of 19 sales under Rule 10b5-1 plans· latest Form 4 filed Nov 19, 2026

Insider Buying

$3.9M

reported purchases (SEC code P)

Insider Selling

$4.0M

reported sales (SEC code S)

Unique Insiders

8

in the rolling window

Latest filing

Nov 19, 2026

Powl Brian T.

Kura Oncology, Inc. (KURA) has 38 SEC Form 4 filings (60 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Nov 19, 2026.

Inside the rolling window, 8 insiders at Kura Oncology, Inc. reported 4 open-market purchases totaling $3.9M and 33 open-market sales totaling $4.0M. The most active filer is Chief Commercial Officer Powl Brian T. with 9 filings. Insiders have net bought $642K over the trailing 6 months. The largest single insider purchase in this window was $1.2M by President and CEO WILSON TROY EDWARD on Aug 24, 2026. The most recent open-market filing is a sale of 448 shares by Chief Commercial Officer Powl Brian T., dated Nov 19, 2026, worth $3K.

  • Industry:Biotechnology
  • CEO:Troy Wilson
  • Employees:260
  • HQ:San Diego, CA, US
  • IPO:2015-09-16
Source
Sale$3KNov 19SEC ↗
Sale$141KNov 18SEC ↗
Sale$166KNov 18SEC ↗
Sale$52KNov 18SEC ↗
Sale$27KNov 18SEC ↗
Sale$64KNov 18SEC ↗
Sale$68KNov 18SEC ↗
Sale$114KNov 18SEC ↗
Sale$35KNov 18SEC ↗
Purchase$754KNov 17SEC ↗
Purchase$750KNov 17SEC ↗
Sale$89KSep 29SEC ↗
FORD KATHLEENFirst in 4 months
Sale$72KSep 29SEC ↗
FORD KATHLEENFirst in 4 months
Sale$39KSep 29SEC ↗
Leoni MollieFirst in 3 months
Sale$131KSep 29SEC ↗
Leoni MollieFirst in 3 months
Sale$310KSep 29SEC ↗
DOYLE THOMAS JAMESFirst in 8 months
Sale$48KSep 29SEC ↗
Sale$179KSep 29SEC ↗
Sale$166KSep 29SEC ↗
Burrows FrancisFirst in 8 months
Sale$225KSep 25SEC ↗
Powl Brian T.First in 3 months
Sale$52KAug 24SEC ↗
Purchase$1.2MAug 24SEC ↗
Bair Teresa BrophyFirst in 3 months
Sale$398KAug 21SEC ↗
Purchase$1.1MAug 17SEC ↗
Leoni MollieFirst in 5 months
Sale$834KJun 22SEC ↗
Showing 1–25 of 37
1 / 2

Congress trading KURA 1 all-time

  • RRep. Chris JacobsPurchase$1,001 - $15,0002022-12-12

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Frequently asked questions

How many SEC Form 4 insider filings does KURA have?

Kura Oncology, Inc. (KURA) has 38 SEC Form 4 filings (60 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Nov 19, 2026.

When was the most recent SEC Form 4 filing for KURA?

The most recent Form 4 filing for KURA on Tracefour is dated Nov 19, 2026.

Who is the most active insider at KURA?

The most active SEC Form 4 filer at KURA in the rolling window is Chief Commercial Officer Powl Brian T., with 9 filings.

What is the net insider flow at KURA over the last 6 months?

Over the trailing 180 days, insiders at KURA have net bought $642K based on SEC Form 4 disclosures.

What was the largest insider purchase at KURA?

The largest single insider open-market purchase at KURA in the rolling window was $1.2M by President and CEO WILSON TROY EDWARD on 2026-08-24.

What is the total insider buy and sell value at KURA in the current window?

Inside the rolling window, insiders at KURA bought $3.9M and sold $4.0M based on SEC Form 4 filings.

Can I get alerts for KURA insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Kura Oncology, Inc. (KURA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Kura Oncology, Inc. is in the Healthcare sector.